BASELINE ACLF GRADE AND TREATMENT RESPONSE TO TERLIPRESSIN IN PATIENTS WITH HEPATORENAL SYNDROME

被引：0
|
作者：
Subramanian, Ram [1 ]
Olson, Jody [2 ]
Zafar, Zunaira [3 ]
Jamil, Khurram [4 ]
机构：
[1] Emory Univ, Atlanta, GA 30322 USA
[2] Univ Kansas Hosp Author, Kansas City, KS USA
[3] St Mary Hosp, Langhorne, PA USA
[4] Mallinckrodt Pharmaceut, Seattle, WA USA
来源：
CRITICAL CARE MEDICINE | 2023年 / 51卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
1092
引用
收藏
页码：542 / 542
页数：1
相关论文
共 50 条
  • [21] Impact on post liver transplant outcomes of response to treatment with terlipressin and albumin in patients with hepatorenal syndrome
    Vettore, E.
    Piano, S.
    Tonon, M.
    Romano, A.
    Gambino, C.
    Bertoli, E.
    Fasolato, S.
    Zanus, G.
    Boccagni, P.
    Burra, P.
    Cillo, U.
    Angeli, P.
    DIGESTIVE AND LIVER DISEASE, 2019, 51 : E50 - E51
  • [22] Impact on post liver transplant outcomes of response to treatment with terlipressin and albumin in patients with hepatorenal syndrome
    Vettore, Elia
    Piano, Salvatore
    Tonon, Marta
    Romano, Antonietta
    Gambino, Carmine
    Bertoli, Eleonora
    Fasolato, Silvano
    Zanus, Giacomo
    Boccagni, Patrizia
    Burra, Patrizia
    Cillo, Umberto
    Angeli, Paolo
    JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E572 - E572
  • [23] Terlipressin for hepatorenal syndrome
    Gluud, L. L.
    Kjaer, M. S.
    Christensen, E.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2006, (04):
  • [24] Noradrenaline versus terlipressin in the treatment of hepatorenal syndrome
    Singh, V.
    Ghosh, S.
    Chawla, Y.
    Singh, B.
    Sharma, N.
    Bhalla, A.
    Nain, C. K.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2010, 25 : A98 - A98
  • [25] Noradrenaline Versus Terlipressin in the Treatment of Hepatorenal Syndrome
    Singh, Virendra
    Ghosh, Saubhik
    Chawla, Yogesh
    Singh, Baljinder
    Sharma, Navneet
    Bhalla, Ashish
    Nain, Ck
    GASTROENTEROLOGY, 2011, 140 (05) : S958 - S958
  • [26] Terlipressin Treatment Is Associated With Reversal of Hepatorenal Syndrome in Patients With Alcoholic Hepatitis
    Sigal, Samuel h.
    Sanyal, Arun j.
    Frederick, R. todd
    Weinberg, Ethan m.
    Pappas, S. chris
    Jamil, Khurram
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (13) : 3455 - +
  • [27] Terlipressin and albumin combination treatment in patients with hepatorenal syndrome type 2
    Marc Nguyen-Tat
    Jaeger, Julia
    Rey, Johannes Wilhelm
    Nagel, Michael
    Labenz, Christian
    Woerns, Marcus-Alexander
    Galle, Peter Robert
    Marquardt, Jens Uwe
    UNITED EUROPEAN GASTROENTEROLOGY JOURNAL, 2019, 7 (04) : 529 - 537
  • [28] Hepatorenal syndrome: Response to terlipressin and albumin and its determinants
    Sarwar, Shahid
    Khan, Anwaar A.
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2016, 32 (02) : 274 - 278
  • [29] Patients with hepatorenal syndrome and lower baseline mean arterial pressure derive significant survival benefit from treatment with terlipressin
    Kwo, Paul Yien
    Pyrsopoulos, Nikolaos T.
    Thuluvath, Paul J.
    Janardhan, Sujit
    Jamil, Khurram
    JOURNAL OF HEPATOLOGY, 2024, 80 : S240 - S241
  • [30] TREATMENT RESPONSE TO TERLIPRESSIN IS UNAFFECTED BY DOSE INTERRUPTIONS IN PATIENTS WITH HEPATORENAL SYNDROME-ACUTE KIDNEY INJURY
    Mumtaz, Khalid
    Bari, Khurram
    Reddy, Gautham
    Regenstein, Fredric
    Zamor, Philippe
    Sass, David
    Jamil, Khurram
    GASTROENTEROLOGY, 2024, 166 (05) : S1581 - S1581
12345